Inder Nagra 4 Chorea

1. Dunger DB, Sperling MA, Acerini CL, et al. European Society for Paediatric Endocrinol-ogy/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics 2004; 113(2):e133-e140.

2. Umpierrez GE, Woo W, Hagopian WA, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes care 1999; 22(9):1517-1523.

3. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Int Med 1999; 159(19):2317-2322.

4. Rosenbloom AL. Hyperglycemic comas in children: new insights into pathophysiology and management. Rev Endocr Metab Disord 2005; 6(4):297-306.

5. Curtis JR, To T, Muirhead S, Cummings E, Daneman D. Recent trends in hospitalization for diabetic ketoacidosis in Ontario children. Diabetes care 2002; 25(9):1591-1596.

6. Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-1996. Arch Dis Child 1999; 81(4):318-323.

7. Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatrics Soc 1992; 40(11):1100-1104.

8. Pinkey JH, Bingley PJ, Sawtell PA, Dunger DB, Gale EA. Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study Group. Diabetologia 1994; 37(1):70-74.

9. Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 1983; 117(5):551-558.

10. Johnson DD, Palumbo PJ, Chu CP. Diabetic ketoacidosis in a community-based population. Mayo Clin Proc 1980; 55(2):83-88.

11. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37(3):278-285.

12. Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care 2000; 23(3):381-389.

13. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24(1):131-153.

14. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 2006; 29(12):2739-2748.

15. McGarry JD, Mannaerts GP, Foster DW. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 1977; 60(1):265-270.

16. Declercq PE, Falck JR, Kuwajima M, Tyminski H, Foster DW, McGarry JD. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. J Biol Chem 1987; 262(20):9812-9821.

17. McGarry JD, Woeltje KF, Kuwajima M, Foster DW. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab Rev 1989; 5(3):271-284.

18. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in diabetes. Diabetes Care 2004; 27(Suppl 1):S94-S102.

19. Burge MR, Hardy KJ, Schade DS. Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency. J Clin Endocrinol Metabolism 1993; 76(5):1192-1208.

20. Haddad NG, Croffie JM, Eugster EA. Pancreatic enzyme elevations in children with diabetic ketoacidosis. J Pediatr 2004; 145(1):122-124.

21. Curzon G, Kantamaneni BD, Callaghan N, Sullivan PA. Brain transmitter precursors and metabolites in diabetic ketoacidosis. J Neurol Neurosurgery Psychiatry 1982; 45(6):489-493.

22. Wootton-Gorges SL, Buonocore MH, Kuppermann N, et al. Cerebral proton magnetic resonance spectroscopy in children with diabetic ketoacidosis. AJNR 2007; 28(5):895-899.

23. Tsalikian E, Becker DJ, Crumrine PK, Daneman D, Drash AL. Electroencephalographic changes in diabetic ketosis in children with newly and previously diagnosed insulin-dependent diabetes mellitus. J Pediatr 1981; 99(3):355-359.

24. Northam EA, Anderson PJ, Werther GA, Warne GL, Andrewes D. Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care 1999; 22(9):1438-1444.

25. Northam E, Bowden S, Anderson V, Court J. Neuropsychological functioning in adolescents with diabetes. J Clin Exp Neuropsychol 1992; 14(6):884-900.

26. Bello FA, Sotos JF. Cerebral oedema in diabetic ketoacidosis in children. Lancet 1990; 336(8706):64.

27. Glaser NS, Wootton-Gorges SL, Buonocore MH, et al. Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes 2006; 7(2):75-80.

28. Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. NE J Med 2001; 344(4):264-269.

29. Edge JA. Cerebral oedema during treatment of diabetic ketoacidosis: are we any nearer finding a cause? Diabetes Metabol Res Rev 2000; 16(5):316-324.

30. Glasgow AM. Devastating cerebral edema in diabetic ketoacidosis before therapy. Diabetes Care 1991; 14(1):77-78.

31. Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990; 13(1):22-33.

32. Rosenbloom AL, Schatz DA, Krischer JP, et al. Therapeutic controversy: prevention and treatment of diabetes in children. J Clin Endocrinol Metabol 2000; 85(2):494-522.

33. Krane EJ, Rockoff MA, Wallman JK, Wolfsdorf JI. Subclinical brain swelling in children during treatment of diabetic ketoacidosis. NE J Med 1985; 312(18):1147-1151.

34. Hoffman WH, Steinhart CM, el Gammal T, Steele S, Cuadrado AR, Morse PK. Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR 1988; 9(4):733-739.

35. Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child 2001; 85(1):16-22.

36. Mahoney CP, Vlcek BW, DelAguila M. Risk factors for developing brain herniation during diabetic ketoacidosis. Pediatr Neurol 1999; 21(4):721-727.

37. Edge JA, Jakes RW, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 2006; 49(9):2002-2009.

38. Glaser NS, Marcin JP, Wootton-Gorges SL, et al. Correlation of Clinical and Biochemical Findings with Diabetic Ketoacidosis-Related Cerebral Edema in Children Using Magnetic Resonance Diffusion-Weighted Imaging. J Pediatr 2008.

39. Carlotti AP, Bohn D, Halperin ML. Importance of timing of risk factors for cerebral oedema during therapy for diabetic ketoacidosis. Arch Disease Child 2003; 88(2):170-173.

40. Arieff AI, Kleeman CR. Cerebral edema in diabetic comas. II. Effects of hyperosmolal-ity, hyperglycemia and insulin in diabetic rabbits. J Clin Endocrinol Metabol 1974; 38(6): 1057-1067.

41. van der Meulen JA, Klip A, Grinstein S. Possible mechanism for cerebral oedema in diabetic ketoacidosis. Lancet 1987; 2(8554):306-308.

42. Pollock AS, Arieff AI. Abnormalities of cell volume regulation and their functional consequences. Am J Physiol 1980; 239(3):F195-F205.

43. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Molecular Neurobiol 2000; 20(2):131-147.

44. Sarker MH, Fraser PA. The role of guanylyl cyclases in the permeability response to inflammatory mediators in pial venular capillaries in the rat. J Physiol 2002; 540(Pt 1):209-218.

45. O'Donnell ME, Martinez A, Sun D. Cerebral microvascular endothelial cell Na-K-Cl cotransport: regulation by astrocyte-conditioned medium. Am J Physiol 1995; 268(3 Pt 1): C747-C754.

46. Kimelberg HK, Rutledge E, Goderie S, Charniga C. Astrocytic swelling due to hypotonic or high K+ medium causes inhibition of glutamate and aspartate uptake and increases their release. J Cereb Blood Flow Metab 1995; 15(3):409-416.

47. Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nature Med 2000; 6(2):159-163.

48. McManus ML, Churchwell KB, Strange K. Regulation of cell volume in health and disease. NE J Med 1995; 333(19):1260-1266.

49. Yang GY, Betz AL. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994; 25(8):1658-1664; discussion 1664-1665.

50. Silver SM, Clark EC, Schroeder BM, Sterns RH. Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. Kidney Int 1997; 51(4):1237-1244.

51. Harris GD, Lohr JW, Fiordalisi I, Acara M. Brain osmoregulation during extreme and moderate dehydration in a rat model of severe DKA. Life Sci 1993; 53(3):185-191.

52. Rose SJ, Bushi M, Nagra I, Davies WE. Taurine fluxes in insulin dependent diabetes mellitus and rehydration in streptozotocin treated rats. Adv Exp Med Biol 2000; 483: 497-501.

53. Cameron FJ, Kean MJ, Wellard RM, Werther GA, Neil JJ, Inder TE. Insights into the acute cerebral metabolic changes associated with childhood diabetes. Diabet Med 2005; 22(5):648-653.

54. Lam TI, Anderson SE, Glaser N, O'Donnell ME. Bumetanide reduces cerebral edema formation in rats with diabetic ketoacidosis. Diabetes 2005; 54(2):510-516.

55. Yuen N, Anderson SE, Glaser N, Tancredi DJ, O'Donnell ME. Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes 2008; 57(10):2588-2594.

56. Isales CM, Min L, Hoffman WH. Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J Diabetes Complications 1999; 13(2):91-97.

57. Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 2004; 89(2):188-194.

58. Marcin JP, Glaser N, Barnett P, et al. Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema. J Pediatr 2002; 141(6):793-797.

59. Fiordalisi I, Novotny WE, Holbert D, Finberg L, Harris GD. An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment. Pediatr Diabetes 2007; 8(3):142-149.

60. Duck SC, Wyatt DT. Factors associated with brain herniation in the treatment of diabetic ketoacidosis. J Pediatr 1988; 113(1 Pt 1):10-14.

61. Hamblin PS, Topliss DJ, Chosich N, Lording DW, Stockigt JR. Deaths associated with diabetic ketoacidosis and hyperosmolar coma. 1973-1988. Med J Aust 1989; 151(8):439, 441432, 444.

62. Chupin M, Charbonnel B, Chupin F. C-peptide blood levels in keto-acidosis and in hyperosmolar non-ketotic diabetic coma. Acta Diabetol Lat 1981; 18(2):123-128.

63. Lorber D. Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am 1995; 79(1):39-52.

64. Lavin PJ. Hyperglycemic hemianopia: a reversible complication of non-ketotic hyper-glycemia. Neurol 2005; 65(4):616-619.

65. Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Physician 2005; 71(9):1723-1730.

66. Fulop M, Tannenbaum H, Dreyer N. Ketotic hyperosmolar coma. Lancet 1973;2(7830):635-639.

67. Guisado R, Arieff AI. Neurologic manifestations of diabetic comas: correlation with biochemical alterations in the brain. Metabolism 1975; 24(5):665-679.

68. Van Harreveld A, Hooper NK, Cusick JT. Brain electrolytes and cortical impedance. Am J Physiol 1961; 201:139-143.

69. Gerich JE, Martin MM, Recant L. Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Diabetes 1971; 20(4):228-238.

70. Maccario M. Neurological dysfunction associated with nonketotic hyperglycemia. Arch Neu-rol 1968; 19(5):525-534.

71. Harden CL, Rosenbaum DH, Daras M. Hyperglycemia presenting with occipital seizures. Epilepsia 1991; 32(2):215-220.

72. Duncan MB, Jabbari B, Rosenberg ML. Gaze-evoked visual seizures in nonketotic hyper-glycemia. Epilepsia 1991; 32(2):221-224.

73. Brazis PW, Lee AG, Graff-Radford N, Desai NP, Eggenberger ER. Homonymous visual field defects in patients without corresponding structural lesions on neuroimaging. J Neurooph-thalmol 2000; 20(2):92-96.

74. Freedman KA, Polepalle s. Transient homonymous hemianopia and positive visual phenomena in nonketotic hyperglycemic patients. Am J Ophthalmol 2004; 137(6):1122-1124.

75. Seo DW, Na DG, Na DL, Moon SY, Hong SB. Subcortical hypointensity in partial status epilepticus associated with nonketotic hyperglycemia. J Neuroimaging 2003; 13(3): 259-263.

76. Oh SH, Lee KY, Im JH, Lee MS. Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases. J Neurol Sci 2002; 200(1-2):57-62.

77. Ahlskog JE, Nishino H, Evidente VG, et al. Persistent chorea triggered by hyperglycemic crisis in diabetics. Mov Disord 2001; 16(5):890-898.

78. Chu K, Kang DW, Kim DE, Park SH, Roh JK. Diffusion-weighted and gradient echo magnetic resonance findings of hemichorea-hemiballismus associated with diabetic hyperglycemia: a hyperviscosity syndrome? Arch Neurol 2002; 59(3):448-452.

79. Iwata A, Koike F, Arasaki K, Tamaki M. Blood brain barrier destruction in hyperglycemic chorea in a patient with poorly controlled diabetes. J Neurol Sci 1999; 163(1):90-93.

80. Fujioka M, Taoka T, Hiramatsu KI, Sakaguchi S, Sakaki T. Delayed ischemic hyperintensity on T1-weighted MRI in the caudoputamen and cerebral cortex of humans after spectacular shrinking deficit. Stroke 1999; 30(5):1038-1042.

81. Shan DE, Ho DM, Chang C, Pan HC, Teng MM. Hemichorea-hemiballism: an explanation for MR signal changes. AJNR 1998; 19(5):863-870.

82. Cochin JP, Hannequin D, Delangre T, Guegan-Massardier E, Augustin P. [Continuous partial epilepsy disclosing diabetes mellitus]. Rev Neurol (Paris) 1994; 150(3):239-241.

83. Tiamkao S, Pratipanawatr T, Nitinavakarn B, Chotmongkol V, Jitpimolmard S. Seizures in nonketotic hyperglycaemia. Seizure 2003; 12(6):409-410.

84. Stahlman GC, Auerbach PS, Strickland WG. Neurologic manifestations of non-ketotic hyperglycemia. J Tenn Med Assoc 1988; 81(2):77-80.

85. Cokar O, Aydin B, Ozer F. Non-ketotic hyperglycaemia presenting as epilepsia partialis continua. Seizure 2004; 13(4):264-269.

86. Hennis A, Corbin D, Fraser H. Focal seizures and non-ketotic hyperglycaemia. J Neurol Neu-rosurg Psychiatry 1992; 55(3):195-197.

87. Brick JF, Gutrecht JA, Ringel RA. Reflex epilepsy and nonketotic hyperglycemia in the elderly: a specific neuroendocrine syndrome. Neurology 1989; 39(3):394-399.

88. Duckrow RB, Beard DC, Brennan RW. Regional cerebral blood flow decreases during hyperglycemia. Ann Neurol 1985; 17(3):267-272.

89. Lammouchi T, Zoghlami F, Ben Slamia L, Grira M, Harzallah MS, Benammou S. [Epileptic seizures in non-ketotic hyperglycemia]. Neurophysiol Clin 2004; 34(3-4):183-187.

90. Ozer F, Mutlu A, Ozkayran T. Reflex epilepsy and non-ketotic hyperglycemia. Epileptic Disord 2003; 5(3):165-168.

91. Raghavendra S, Ashalatha R, Thomas SV, Kesavadas C. Focal neuronal loss, reversible subcortical focal T2 hypointensity in seizures with a nonketotic hyperglycemic hyperosmolar state. Neuroradiol 2007; 49(4):299-305.

92. Singh BM, Strobos RJ. Epilepsia partialis continua associated with nonketotic hyperglycemia: clinical and biochemical profile of 21 patients. Ann Neurol 1980; 8(2):155-160.

93. Maclsaac RJ, Lee LY, McNeil KJ, Tsalamandris C, Jerums G. Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies. Int Med J 2002; 32(8):379-385.

94. Chu CH, Lee JK, Lam HC, Lu CC. Prognostic factors of hyperglycemic hyperosmolar nonketotic state. Chang Gung Med J 2001; 24(6):345-351.

95. Zouvanis M, Pieterse AC, Seftel HC, Joffe BI. Clinical characteristics and outcome of hyperglycaemic emergencies in Johannesburg Africans. Diabet Med 1997; 14(7): 603-606.

96. Pinies JA, Cairo G, Gaztambide S, Vazquez JA. Course and prognosis of 132 patients with diabetic non ketotic hyperosmolar state. Diabetes Metabol 1994; 20(1):43-48.

97. Rolfe M, Ephraim GG, Lincoln DC, Huddle KR. Hyperosmolar non-ketotic diabetic coma as a cause of emergency hyperglycaemic admission to Baragwanath Hospital. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1995; 85(3):173-176.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment